FDA to Consider Adding Johnson & Johnson Vaccine to Rollout

The FDA could approve a new one-shot COVID vaccine by Friday, as Congress decides on COVID relief bill details. The Johnson & Johnson one-shot vaccine is over 20 percent less effective than Pfizer and Moderna’s, but still far better than a flu shot.